Asset Details
Do you wish to reserve the book?
In new crowdfunding trend, donors decide fate of clinical trials
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
In new crowdfunding trend, donors decide fate of clinical trials
Do you wish to request the book?
In new crowdfunding trend, donors decide fate of clinical trials
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
In new crowdfunding trend, donors decide fate of clinical trials
2015
Overview
Some aspects of this forced negotiation might also be unappealing to developers of brand-name biologics. For example, if the two parties cant agree on which patents are involved, the biosimilar maker can limit the number of patents contested in the first round of litigation to as few as one.
Publisher
Nature Publishing Group US,Nature Publishing Group
Subject
